Keeping Track: US FDA Clears Kisqali For Breast Cancer And Keytruda In Lymphoma, But Turns Down AZ's ZS-9 Again

 
• By Bridget Silverman

The latest drug development news and highlights from our FDA Performance Tracker.

More from Approvals

More from Product Reviews